High investment costs required for R&D and the development of effective zika virus vaccines
serves as a restraining factor for the global zika vaccines market.
Request For Customization of Research Report @ https://bit.ly/2SxqKHA
While major of the Zika virus cases occur in tropical regions such as Brazil, Paraguay,
Venezuela, Colombia and Suriname, there are higher chances of mosquito infections in tropical
areas of the U.S. like Texas and Florida. According to Pan American Health Organization,
around 1,246 suspected and confirmed cases were reported between epidemiological week (EW)
10 and EW 14 of 2016 in the sub region which involves Brazil, Argentina, Peru and Ecuador.
Competitive Landscape
Some key players operating in the zika vaccines market are Cerus Corporation, Biken Inc,
GlaxoSmithKline plc, Bharat Biotech International Pvt. Ltd, GeneOne Life Science, Inovio
Pharmaceuticals, Immunovaccine Inc., NewLink Genetics Corp. and Sanofi S.A. The companies
launched various R&D measures and clinical trials to attain immunogenicity against zika virus.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com